Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Lung Cancer

Free Subscription Articles published in J Immunol Retrieve available abstracts of 11 articles: HTML format

Single Articles

January 2024
1. TOYOFUKU T, Ishikawa T, Nojima S, Kumanogoh A, et al
   Efficacy against Lung Cancer Is Augmented by Combining Aberrantly N-Glycosylated T Cells with a Chimeric Antigen Receptor Targeting Fragile X Mental Retardation 1 Neighbor.
   J Immunol. 2024 Jan 12:ji2300618. doi: 10.4049/jimmunol.2300618.
   PubMed     Abstract available
   
   
   October 2023
2. RAV E, Maegawa S, Gopalakrishnan V, Gordon N, et al
   Overview of CD70 as a Potential Therapeutic Target for Osteosarcoma.
   J Immunol. 2023;211:1067-1072.
   PubMed     Abstract available
   
   
   June 2023
3. LIU C, Liu T, Hu Y, Zeng X, et al
   G Protein-Coupled Receptor 56 Characterizes CTLs and Reflects the Progression of Lung Cancer Patients.
   J Immunol. 2023 Jun 28:ji2101048. doi: 10.4049/jimmunol.2101048.
   PubMed     Abstract available
   
   
   September 2022
4. FAN TW, Daneshmandi S, Cassel TA, Uddin MB, et al
   Polarization and beta-Glucan Reprogram Immunomodulatory Metabolism in Human Macrophages and Ex Vivo in Human Lung Cancer Tissues.
   J Immunol. 2022 Sep 23. pii: jimmunol.2200178. doi: 10.4049/jimmunol.2200178.
   PubMed     Abstract available
   
   
   August 2022
5. YOO KJ, Johannes K, Gonzalez LE, Patel A, et al
   LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade.
   J Immunol. 2022;209:510-525.
   PubMed     Abstract available
   
   
   January 2022
6. ZHENG Y, Chen Z, Zhou B, Chen S, et al
   PRMT5 Deficiency Enforces the Transcriptional and Epigenetic Programs of Klrg1(+)CD8(+) Terminal Effector T Cells and Promotes Cancer Development.
   J Immunol. 2022;208:501-513.
   PubMed     Abstract available
   
   
   September 2021
7. LI Z, Gao Y, He C, Wei H, et al
   Purinergic Receptor P2Y6 Is a Negative Regulator of NK Cell Maturation and Function.
   J Immunol. 2021;207:1555-1565.
   PubMed     Abstract available
   
   
   April 2021
8. CHEN CW, Bennion KB, Swift DA, Morrow KN, et al
   Tumor-Specific T Cells Exacerbate Mortality and Immune Dysregulation during Sepsis.
   J Immunol. 2021 Apr 28. pii: jimmunol.2000865. doi: 10.4049/jimmunol.2000865.
   PubMed     Abstract available
   
   
   March 2021
9. AFROJ T, Mitsuhashi A, Ogino H, Saijo A, et al
   Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes.
   J Immunol. 2021;206:1204-1214.
   PubMed     Abstract available
   
   
   November 2020
10. YI FS, Zhang X, Zhai K, Huang ZY, et al
    TSAd Plays a Major Role in Myo9b-Mediated Suppression of Malignant Pleural Effusion by Regulating TH1/TH17 Cell Response.
    J Immunol. 2020;205:2926-2935.
    PubMed     Abstract available
    
    
    
11. KOHNO M, Murakami J, Wu L, Chan ML, et al
    Foxp3(+) Regulatory T Cell Depletion after Nonablative Oligofractionated Irradiation Boosts the Abscopal Effects in Murine Malignant Mesothelioma.
    J Immunol. 2020;205:2519-2531.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.